Evidium
Evidium is a healthcare AI company based in San Francisco, focused on developing referenced AI and world models for healthcare. These systems represent medical knowledge and clinical states to enhance decision-making in care, research, and coverage. Founded around 2020 or 2021, Evidium aims to connect science, practice, and outcomes to support a learning health system. The company offers a neurosymbolic AI platform that transforms medical evidence into computable knowledge. This platform provides transparent reasoning, risk forecasts, and next-best-action support, facilitating clinical workflow transformation and knowledge dissemination. Its main product, the Referenced AI Platform, models patient trajectories and care journeys, helping healthcare organizations make informed decisions. Evidium targets a diverse audience, including health systems, clinicians, insurers, and pharmaceutical companies. The company has raised funding, including a reported $22 million in a Series A round, with investments from various venture firms.